Open-label phase 1 study of EVO101 in healthy adult volunteers
Latest Information Update: 30 Sep 2022
At a glance
- Drugs EVO 101 (Primary)
- Indications Atopic dermatitis; Rosacea
- Focus Adverse reactions
- Sponsors Evommune
Most Recent Events
- 28 Sep 2022 Results published in an Evommune Media Release.
- 28 Sep 2022 Status changed from recruiting to completed, according to an Evommune media release.
- 24 Mar 2022 New trial record